DE-THE-LYCRA-COMPANY
1.6.2022 11:02:07 CEST | Business Wire | Press release
The LYCRA Company , a global leader in developing innovative fiber and technology solutions for the textile and apparel industry, will join a panel discussion at the inaugural United Nations Conscious Fashion and Lifestyle Network Annual Meeting taking place at the United Nations Headquarters in New York City on June 2.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220601005251/en/
With its recent commercialization of COOLMAX® and THERMOLITE® fibers made from 100% textile waste, The LYCRA Company is uniquely positioned to participate in the discussion titled Responsible Consumption and Production: Designing for Our Times . Jean Hegedus, sustainability director, The LYCRA Company, will share her perspective on how the company is scaling recycling solutions to help address the challenge of textile waste.
The meeting will welcome United Nations Conscious Fashion and Lifestyle Network advisory committee members and registered partnerships by industry stakeholders, media, Governments and United Nations system entities to highlight actions, solutions, and progress from the fashion and lifestyle sectors to advance sector engagement in the implementation of the Sustainable Development Goals adopted by the United Nations Member States in 2015. Discussions will focus on confronting the climate crisis, achieving gender equality throughout the value chain, and ensuring a resilient post-pandemic recovery.
“The LYCRA Company recognizes that the journey towards a more sustainable future is a collective effort across the industry,” said Kerry Bannigan, executive director, Fashion Impact Fund. “We are thrilled to have them join our first annual meeting to discuss solutions that will accelerate the fashion and lifestyle sector’s implementation of the Sustainable Development Goals.”
As the apparel industry looks to rapidly develop solutions for a circular economy, The LYCRA Company is focused on a variety of fiber and fabric innovations that reduce or divert waste, keeping materials in use and out of landfills. The company’s EcoMade family of recycled offerings includes LYCRA® , COOLMAX® and THERMOLITE® fibers made from both pre- and post-consumer waste. The LYCRA Company invites the industry to Keep in the Loop with LYCRA to learn about its latest sustainable innovations and circularity advancements, while also promoting collaboration.
The United Nations Conscious Fashion and Lifestyle Network’s inaugural annual meeting is co-convened by the United Nations Office for Partnerships and the Fashion Impact Fund.
Spokesperson Biography:
Jean Hegedus is the sustainability director for The LYCRA Company. Ms. Hegedus has over 35 years of experience in the textile industry, working first with The DuPont Company, and then INVISTA, before moving to The LYCRA Company in 2019. Over the course of her career, she has held a variety of positions in public affairs, marketing, licensing and branding. She began working in the denim segment in 2007, bringing several important innovations to market, including LYCRA® XFIT, LYCRA® dualFX® , LYCRA® BEAUTY, and LYCRA® EcoMade technologies. It was also her work within the denim segment that heightened her awareness of the need for more sustainable solutions, and in July of 2019, she was appointed sustainability director for The LYCRA Company. Ms. Hegedus has a master’s degree in communications from the University of Delaware.
About The LYCRA Company
The LYCRA Company innovates and produces fiber and technology solutions for the apparel and personal care industries. Headquartered in Wilmington, Delaware, The LYCRA Company is recognized worldwide for its innovative products, technical expertise, sustainable solutions, and unmatched marketing support. The LYCRA Company owns leading consumer and trade brands: LYCRA® , LYCRA HyFit® , LYCRA® T400® , COOLMAX® , THERMOLITE® , ELASPAN® , SUPPLEX® , and TACTEL® . The LYCRA Company’s legacy stretches back to 1958 with the invention of the original spandex yarn, LYCRA® fiber. Today, The LYCRA Company focuses on adding value to its customers’ products by developing unique innovations designed to meet the consumer’s need for comfort and lasting performance. For more information, visit www.thelycracompany.com .
LYCRA® is a trademark of The LYCRA Company.
About the United Nations Conscious Fashion and Lifestyle Network
The Conscious Fashion and Lifestyle Network is a United Nations (UN) hosted online platform for industry stakeholders, media, Governments, and UN system entities. The network showcases and enables collaborations that accelerate the implementation of the Sustainable Development Goals. The United Nations Conscious Fashion and Lifestyle Network is a joint initiative of the United Nations Office for Partnerships, the Division for Sustainable Development Goals - United Nations Department of Economic and Social Affairs, and the Fashion Impact Fund. The leading entities of the network convene periodic events aligned with key meetings on the UN calendar and publish reports on the network’s achievements.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220601005251/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk28.8.2026 10:00:00 CEST | Press release
Analyses from the multinational MILOS study show that LDL-C reductions achieved with up to one year of treatment with bempedoic acid-containing therapies translate to a 17.1% relative reduction and a 4.8% absolute reduction in predicted 10-year cardiovascular risk.1 Real-world data demonstrated clinically relevant mean LDL-C reductions of at least 24.9%, regardless of patient gender or glycaemic status, after one year of follow-up.2,3 Findings presented at ESC Congress 2026 reinforce the clinical value of bempedoic acid in routine clinical practice, and demonstrate the continued investment of Daiichi Sankyo in addressing outstanding unmet needs in cardiovascular disease (CVD). Daiichi Sankyo (TSE:4568) today announced new results from the MILOS study that demonstrate the real-world impact of bempedoic acid administered either alone or as a fixed-dose combination with ezetimibe, in the management of dyslipidaemia. Presented at the European Society of Cardiology Congress 2026 in Munich,
TVS Motor Company Appoints Peyman Kargar as Director and Chief Executive Officer28.8.2026 09:31:00 CEST | Press release
Peyman Kargar appointed Director and Chief Executive Officer of TVS Motor Company, effective January 27, 2027 K. N. Radhakrishnan to continue as Director and Chief Executive Officer until then and subsequently will serve as Non-Executive Director up to the date of the ensuing AGM scheduled in July 2027 Appointment supports TVS Motor Company's next phase of growth and innovation TVS Motor Company, part of TVS VENU and a leading global manufacturer of two and three-wheelers, today announced the appointment of Peyman Kargar as Director and Chief Executive Officer, effective January 27, 2027. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260827012301/en/ Peyman Kargar Peyman will succeed K. N. Radhakrishnan, who will continue in his role until then to ensure a seamless transition. Following the transition, Radhakrishnan will serve as Non-Executive Director up to the date of the ensuing AGM scheduled in July 2027. He has been a
Philips and Imricor Launch Cardiac Interventional MR Lab Solution, Expanding Longstanding Collaboration27.8.2026 21:27:00 CEST | Press release
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Imricor Medical Systems (ASX: IMR), a pioneer and world-leading developer of MR-compatible products for interventional MR procedures, today announced a new Interventional MR (iMR) lab solution for Philips 1.5T MR. The first commercially available configuration* combines Philips’ 1.5T MRI platform and Imricor's portfolio of iMR systems and consumables, enabling an MR-guided workflow for cardiac intervention, without compromising on MR field strength. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260827693715/en/ Meeting the need for greater tissue insight during cardiac intervention Cardiac arrhythmias affect millions of people worldwide, and catheter ablation is an established and increasingly utilized treatment for many complex cardiac arrhythmias. Yet today, these procedures continue to rely primarily on X-ray fluoroscopy, which provides only
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom